|
|
||||||||
RAPID COMMUNICATION |
Prince Henrys Institute of Medical Research, Clayton, Australia
(Requests for offprints should be addressed to C Chen, Prince Henrys Institute of Medical Research, P O Box 5152, Clayton, Victoria 3168, Australia; Email: chen.chen{at}phimr.monash.edu.au)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Activins have roles in regulating pituitary and reproductive function, controlling, for example, the production of pituitary follicle-stimulating hormone (FSH) (Massague 1998). Activin A is a member of the activin family and is a dimer composed of two activin ßA-subunits. Apart from the classical role of activins in reproductive control, activin A has also been shown to effect ion channel function in different endocrine tissues. Activin A is located in insulin-containing human pancreatic ß-cells (Wada et al. 1996) and increases insulin secretion in the presence of glucose in human pancreatic islets (Florio et al. 2000). Activin A closes KATP channels and increases Ca2+ channel amplitude in HIT-T15 insulinoma cells, resulting in membrane depolarization and Ca2+ entry (Mogami et al. 1995). Activin A also stimulates FSH secretion by causing membrane depolarization and the opening of Ca2+ channels in human FSH-secreting tumor cells (Takano et al. 1992, Takano et al. 1994). Neuronal survival of rat hippocampal cultures is also promoted by activin A and this effect is blocked by Ca2+ channel antagonists (Iwahori et al. 1997).
Activin signalling components are expressed in the adrenal cortex and activin A reduces secretion of several steroid hormones from this tissue (Vanttinen et al. 2003). mRNA for activin A and its receptor has been identified in human fetal and adult adrenal cortical cells and cultured adrenocortical cell lines, and adrenocorticotrophin induces secretion of activin A from these cell types (Vanttinen et al. 2002). The adrenal cortex is located within the adrenal gland, a tissue that also contains the adrenal medulla. The primary function of the adrenal medulla is catecholamine synthesis and secretion, which is carried out by chromaffin cells. Activin A and its receptors are expressed in human pheochromocytomas, a form of adrenal medullary tumor, and production of activin A in cultured pheochromocytoma cells is induced through the protein kinase A pathway (Liu et al. 2000).
Although activin A is known to stimulate hormone secretion from several endocrine tissues, activin signalling components are present in the adrenal gland and activin A is secreted from the adrenal cortex, it remains unknown whether activin A effects catecholamine secretion from neighbouring adrenal medullary chromaffin cells. We present in this report the first evidence that catecholamine secretion from single rat chromaffin cells can be stimulated by activin A. This represents a previously undiscovered physiological pathway involving an important signalling molecule regulating the secretion of a hormone which has widespread homeostatic influences.
| Materials and Methods |
|---|
|
|
|---|
Catecholamine release from single chromaffin cells was measured using amperometry (Chow et al. 1992). A carbon-fibre electrode (ProCFE, Dagan Corporation, Minneapolis, MN, USA) was carefully placed on an individual chromaffin cell and +800 mV applied to the electrode under voltage clamp conditions. The current due to catecholamine oxidation at the tip of the electrode was recorded using an EPC-9 amplifier and Pulse software (HEKA Electronic, Lambrecht, Germany), sampled at 10 kHz and low-pass filtered at 1 kHz. For quantitative analysis the Pulse files were converted to Axon Binary Files (ABF Utility, version 2.1, Synaptosoft, Decatur, GA, USA) and the secretory spikes analysed (Mini Analysis, version 6.0.1, Synaptosoft, Decatur) for a period of 60 s from the start of exposure to the various treatments. The total charge released over this 60 s period was calculated as the average charge of each secretory event multiplied by the number of events within 60 s. The charge (in picocoulombs, pC) of a single secretory event is simply the area under each spike (charge is the product of current and time), which is automatically calculated by the Mini Analysis software.
The standard saline contained (mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 D-glucose, 10 Hepes (pH 7.4). High K+-containing solution was the same as control bath solution except that 70 mM K+ replaced an equimolar amount of NaCl. All solutions with or without the addition of activin or cadmium (Cd2+) were applied to cells using a gravity perfusion system, the outlet of which was placed within 500 µm of the recorded cell. All other reagents were obtained from Sigma-Aldrich. All experiments were carried out at room temperature (2224 °C).
The equation used for the EC50 calculation and the creation of the sigmoidal doseresponse curve was obtained from the graphing and analysis software used (Prism 3.0, GraphPad Software, San Diego, CA, USA) and is as follows:
![]() |
where:
Hill slope was calculated to be 6
All data are displayed as mean ± S.E.M. and data were tested for significant differences using one-way ANOVA for analysis between different groups and Students paired t-test for comparisons within groups. P<0.05 was set as the limit for statistical significance.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Our results indicate that an activin A concentration of 2 nM is the lowest concentration that gives maximal effects in stimulating catecholamine secretion. This is in close agreement with a previous result showing that the same activin A concentration has significant effects on insulin secretion and ion channel modulation and maximal effects on stimulating Ca2+ influx in doseresponse analysis (Mogami et al. 1995, Fukuhara et al. 1997, Florio et al. 2000).
Previous work has illustrated that the effects of activin A can occur through the manipulation of ion channel function in endocrine cells such as insulin-secreting ß-cells (Mogami et al. 1995) and FSH-secreting tumor cells (Takano et al. 1992, Takano et al. 1994). This new finding that activin A stimulates catecholamine release from chromaffin cells is physiologically important given the many important roles that catecholamines play in homeostatic regulation. These roles include the triggering of the classical flight or fight response, regulation of heart rate and blood pressure as well as fetal survival during episodes of intrauterine stress (Phillippe 1983).
Our results illustrate that the level of catecholamine secretion stimulated by activin A is similar in magnitude to that caused by membrane depolarization induced by an increased external K+ concentration. This is further reinforced by the similarity in all spike parameters analysed from our experiments. As well as this, Ca2+ entry through voltage-gated Ca2+ channels is required for activin-induced secretion based on the fact that the Ca2+ channel antagonist, Cd2+, blocks activin-induced secretion. Thus, activin A seems to cause membrane depolarization as this is required for the opening of these voltage-gated Ca2+ channels. Given that activin A induces catecholamine secretion within approximately 1030 seconds of being applied, we hypothesize that this secretion is caused either by direct effects of activin A on certain ion channels (such as through the reduced opening of K+ channels, for example) or by indirect effects on such channels through a more complex signalling cascade.
This report examines only the end point of the signalling cascade, secretory vesicle exocytosis, within chromaffin cells. Further investigations will need to be carried out to find whether this effect of activin A is caused by ion channel modulation, what intracellular mechanisms are involved in this response and whether other members of the TGF-ß family cause similar effects to those reported here by activin A.
| Acknowledgements |
|---|
| Funding |
|---|
This work is supported by Australian NHMRC and the TM Ramsay Fellowship award. The authors declare that there is no conflict of interest that would prejudice impartiality.
| References |
|---|
|
|
|---|
Chow RH, von Ruden L & Neher E 1992 Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells. Nature 356 6063.[CrossRef][Medline]
Florio P, Luisi S, Marchetti P, Lupi R, Cobellis L, Falaschi C, Sugino H, Navalesi R, Genazzani AR & Petraglia F 2000 Activin A stimulates insulin secretion in cultured human pancreatic islets. Journal of Endocrinological Investigation 23 231234.[ISI][Medline]
Fukuhara S, Mukai H & Munekata E 1997 Activin A and all-trans-retinoic acid cooperatively enhanced the functional activity of L-type Ca2+ channels in the neuroblastoma C1300 cell line. Biochemical and Biophysical Research Communications 241 363368.[CrossRef][Medline]
Harrison CA, Gray PC, Vale WW & Robertson DM 2005 Antagonists of activin signaling: mechanisms and potential biological applications. Trends in Endocrinology and Metabolism 16 7378.[CrossRef][ISI][Medline]
Iwahori Y, Saito H, Torii K & Nishiyama N 1997 Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Research 760 5258.[CrossRef][ISI][Medline]
Kikuta A & Murakami T 1982 Microcirculation of the rat adrenal gland: a scanning electron microscope study of vascular casts. American Journal of Anatomy 164 1928.
Liu J, Heikkila P, Kahri AI & Voutilainen R 2000 Expression of activin A and its receptors in human pheochromocytomas. Journal of Endocrinology 165 503508.[Abstract]
Massague J 1998 TGF-beta signal transduction. Annual Review of Biochemistry 67 753791.[CrossRef][ISI][Medline]
Mogami H, Kanzaki M, Nobusawa R, Zhang YQ, Furukawa M & Kojima I 1995 Modulation of adenosine triphosphate-sensitive potassium channel and voltage-dependent calcium channel by activin A in HIT-T15 cells. Endocrinology 136 29602966.[Abstract]
Phillippe M 1983 Fetal catecholamines. American Journal of Obstetrics and Gynecology 146 840855.[ISI][Medline]
Takano K, Yamashita N, Kojima I, Kitaoka M, Teramoto A & Ogata E 1992 Effects of activin A and somatostatin on intact FSH secretion and intracellular Ca2+ concentration in human FSH-secreting pituitary adenoma cells. Biochemical and Biophysical Research Communications 182 14081415.[CrossRef][Medline]
Takano K, Ogata E & Yamashita N 1994 Effects of activin A on ionic channels in human FSH-secreting tumour cells. Journal of Physiology 474 6573.
Vanttinen T, Kuulasmaa T, Liu J & Voutilainen R 2002 Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. Journal of Clinical Endocrinology and Metabolism 87 42574263.
Vanttinen T, Liu J, Kuulasmaa T, Kivinen P & Voutilainen R 2003 Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. Journal of Endocrinology 178 479489.[Abstract]
Wada M, Shintani Y, Kosaka M, Sano T, Hizawa K & Saito S 1996 Immunohistochemical localization of activin A and follistatin in human tissues. Endocrine Journal 43 375385.[ISI][Medline]
Received 19 April 2005
Accepted 23 June 2005
Made available online as an Accepted Preprint 24 June 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |